English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
新冠疫情多地爆發 楷和醫療求診數量增
Jun 24, 2025 08:04 HKT
ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology
Jun 23, 2025 21:00 HKT
華領醫藥在2025ADA科學年會公佈多格列艾汀與DPP-4抑制劑聯用在恢復血糖穩態的同時有望降低血脂
Jun 23, 2025 15:09 HKT
华领医药在2025ADA科学年会公布多格列艾汀与DPP-4抑制剂联用在恢复血糖稳态的同时有望降低血脂
Jun 23, 2025 11:11 HKT
康希諾重磅推出優佩欣疫苗 為兒童健康保駕護航的創新之選
Jun 21, 2025 12:09 HKT
康希诺重磅推出优佩欣疫苗 为儿童健康保驾护航的创新之选
Jun 20, 2025 17:58 HKT
雲頂新耀加速全球佈局 耐賦康(R)與EVER001雙引擎釋放創新藥價值潛力
Jun 20, 2025 14:49 HKT
云顶新耀加速全球布局 耐赋康(R)与EVER001双引擎释放创新药价值潜力
Jun 20, 2025 14:42 HKT
雅各臣公佈二零二五財年全年業績 持續經營業務溢利飈升43.1%至3.0億港元
Jun 13, 2025 19:06 HKT
雅各臣公布二零二五财年全年业绩 持续经营业务溢利飙升43.1%至3.0亿港元
Jun 13, 2025 18:53 HKT
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million
Jun 12, 2025 21:07 HKT
健倍苗苗二零二五財年全年業績表現亮眼 純利飆升51.2%至1.97億港元
Jun 12, 2025 20:58 HKT
健倍苗苗二零二五财年全年业绩表现亮眼 纯利飙升51.2%至1.97亿港元
Jun 12, 2025 20:48 HKT
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
Jun 12, 2025 16:38 HKT
耐賦康(R)與EVER001協同發力 雲頂新耀推動腎病治療進入精準管理新階段
Jun 12, 2025 16:31 HKT
耐赋康(R)与EVER001协同发力 云顶新耀推动肾病治疗进入精准管理新阶段
Jun 12, 2025 16:26 HKT
Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025
Jun 09, 2025 12:52 HKT
雲頂新耀EVER001亮相ERA 2025 探索原發性膜性腎病治療新路徑
Jun 09, 2025 12:47 HKT
云顶新耀EVER001亮相ERA 2025 探索原发性膜性肾病治疗新路径
Jun 09, 2025 12:35 HKT
Traditional Chinese Medicine Consumption Shows Promising Outlook, with Neautus's Market Leadership Becoming Increasingly Evident
Jun 03, 2025 16:56 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: